(Q44483127)

English

A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

author name string

David Hackett

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Vincent Haudiquet

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Eliseo Salinas

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

European Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

182-187

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Concerns about clinical drug trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900046-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo response in anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900046-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900046-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900046-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900046-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Anxiolytic drugs: dependence, addiction and abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900046-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900046-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of benzodiazepines in anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900046-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-9338(03)00046-4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44483127&oldid=2025512344"